If I was in charge of DNDN, my decision to unblind 9902b early to look at TTP or not will depend on whether or not I feel that the survival interim look has a better chance at statistical significance than TTP...
For instance, if the interim look for survival has a 50% chance of having a p value less that 0.05 but TTP has a 80% chance of statistical significance, then I would probably elect to go early with TTP since my argument for approval is going to be based on supportiveness to 9901... Of course, if the interim has a decent chance at meeting the stringent interim survival p value, then I would wait till then before analyzing any data...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.